Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation

Nature Communications

Volumn 7, Issue , 2016, Pages

  Zhao, Chuntao ^a,b   Deng, Yaqi ^a,b   Liu, Lei ^a   Yu, Kun ^a   Zhang, Liguo ^b   Wang, Haibo ^b   He, Xuelian ^b   Wang, Jincheng ^b,c   Lu, Changqing ^a   Wu, Laiman N ^b   Weng, Qinjie ^c   Mao, Meng ^a   Li, Jianrong ^d   Van Es, Johan H ^e   Xin, Mei ^b   Parry, Lee ^f   Goldman, Steven A ^g   Clevers, Hans ^e   Lu, Q Richard ^a,b,h  

^a SICHUAN UNIVERSITY   (China)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d TEXAS A AND M UNIVERSITY   (United States)

^e HUBRECHT INSTITUTE   (Netherlands)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^h FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CHOLESTEROL; TRANSCRIPTION FACTOR 7 LIKE 2; PROTEIN BINDING; SOX10 PROTEIN, MOUSE; TCF7L2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX; ZBTB33 PROTEIN, MOUSE;

CYTOGENETICS; GENE; GENE EXPRESSION; GENOME; INHIBITION; INHIBITOR; ORGANIC COMPOUND; PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PROTEIN PROTEIN INTERACTION; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; METABOLISM; NERVOUS SYSTEM; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ANIMALS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVOUS SYSTEM; OLIGODENDROGLIA; PROTEIN BINDING; SIGNAL TRANSDUCTION; SOXE TRANSCRIPTION FACTORS; SPECIES SPECIFICITY; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTION FACTORS;

EID: 84960532324     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10883     Document Type: Article

References (66)

1. Zalc, B. & Colman, D. R. Origins of vertebrate success. Science 288, 271-272 (2000).
2. Molofsky, A. V., et al. Astrocyte-encoded positional cues maintain sensorimotor circuit integrity. Nature 509, 189-194 (2014).
3. McKenzie, I. A., et al. Motor skill learning requires active central myelination. Science 346, 318-322 (2014).
4. Bercury, K. K. & Macklin, W. B. Dynamics and mechanisms of CNS myelination. Dev. Cell 32, 447-458 (2015).
5. Han, X., et al. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell 12, 342-353 (2013).
6. Zuchero, J. B. & Barres, B. A. Intrinsic and extrinsic control of oligodendrocyte development. Curr. Opin. Neurobiol. 23, 914-920 (2013).
7. He, L. & Lu, Q. R. Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues. Neurosci. Bull. 29, 129-143 (2013).
8. Fancy, S. P., et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 23, 1571-1585 (2009).
9. Ye, F., et al. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat. Neurosci. 12, 829-838 (2009).
10. McClain, C. R., Sim, F. J. & Goldman, S. A. Pleiotrophin suppression of receptor protein tyrosine phosphatase-beta/zeta maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. J. Neurosci. 32, 15066-15075 (2012).
11. Shimizu, T., et al. Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev. Biol. 282, 397-410 (2005).
12. Feigenson, K., Reid, M., See, J., Crenshaw, 3rd E. B. & Grinspan, J. B. Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol. Cell. Neurosci. 42, 255-265 (2009).
13. Azim, K. & Butt, A. M. GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 59, 540-553 (2011).
14. Fancy, S. P., et al. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat. Neurosci. 14, 1009-1016 (2011).
15. Lang, J., et al. Adenomatous polyposis coli regulates oligodendroglial development. J. Neurosci. 33, 3113-3130 (2013).
16. Clevers, H. & Nusse, R. Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205 (2012).
17. Schuijers, J., Mokry, M., Hatzis, P., Cuppen, E. & Clevers, H. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J. 33, 146-156 (2014).
18. Hammond, E., et al. The Wnt effector transcription factor 7-like 2 positively regulates oligodendrocyte differentiation in a manner independent of Wnt/beta-catenin signaling. J. Neurosci. 35, 5007-5022 (2015).
19. Arce, L., Yokoyama, N. N. & Waterman, M. L. Diversity of LEF/TCF action in development and disease. Oncogene 25, 7492-7504 (2006).
20. Van Es, J. H., et al. A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. Mol. Cell. Biol. 32, 1918-1927 (2012).
21. Korinek, V., et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19, 379-383 (1998).
22. Xin, M., et al. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J. Neurosci. 25, 1354-1365 (2005).
23. Deng, Y., et al. Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-Anchored EGFP. Genesis 52, 341-349 (2014).
24. Hamilton, T. G., Klinghoffer, R. A., Corrin, P. D. & Soriano, P. Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms. Mol. Cell. Biol. 23, 4013-4025 (2003).
25. Lappe-Siefke, C., et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33, 366-374 (2003).
26. Franklin, R. J. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 3, 705-714 (2002).
27. Yu, Y., et al. Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 152, 248-261 (2013).
28. Creyghton, M. P., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21931-21936 (2010).
29. Santos-Rosa, H., et al. Active genes are tri-methylated at K4 of histone H3. Nature 419, 407-411 (2002).
30. Heinz, S., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
31. Hatzis, P., et al. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol. Cell. Biol. 28, 2732-2744 (2008).
32. Boj, S. F., et al. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151, 1595-1607 (2012).
33. Ruzov, A., et al. The interaction of xKaiso with xTcf3: a revised model for integration of epigenetic and Wnt signalling pathways. Development 136, 723-727 (2009).
34. Park, J. I., et al. Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev. Cell 8, 843-854 (2005).
35. Prokhortchouk, A., et al. The p120 catenin partner Kaiso is a DNA methylationdependent transcriptional repressor. Genes Dev. 15, 1613-1618 (2001).
36. Munemitsu, S., Albert, I., Rubinfeld, B. & Polakis, P. Deletion of an aminoterminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol. Cell. Biol. 16, 4088-4094 (1996).
37. Korinek, V., et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275, 1784-1787 (1997).
38. Schuster, N., et al. TGF-beta induces cell death in the oligodendroglial cell line OLI-neu. Glia 40, 95-108 (2002).
39. Prokhortchouk, A., et al. Kaiso-deficient mice show resistance to intestinal cancer. Mol. Cell. Biol. 26, 199-208 (2006).
40. Srinivasan, R., et al. Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve. Nucleic Acids Res. 40, 6449-6460 (2012).
41. Stolt, C. C., et al. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 16, 165-170 (2002).
42. Espenshade, P. J. & Hughes, A. L. Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 41, 401-427 (2007).
43. Xu, G., Muller, O., Stange, E. F. & Fuchs, M. Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice. Biochim. Biophys. Acta 1688, 274-279 (2004).
44. Mathews, E. S., et al. Mutation of 3-hydroxy-3-methylglutaryl CoA synthase I reveals requirements for isoprenoid and cholesterol synthesis in oligodendrocyte migration arrest, axon wrapping, and myelin gene expression. J. Neurosci. 34, 3402-3412 (2014).
45. Saher, G., et al. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468-475 (2005).
46. Jurevics, H. & Morell, P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64, 895-901 (1995).
47. Smith, M. E. & Hasinoff, C. M. Inhibitors of cholesterol synthesis and myelin formation. Lipids 5, 665-671 (1970).
48. Dai, Z. M., et al. Stage-specific regulation of oligodendrocyte development by Wnt/beta-catenin signaling. J. Neurosci. 34, 8467-8473 (2014).
49. Fu, H., et al. A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. J. Neurosci. 29, 11399-11408 (2009).
50. He, Y., et al. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55, 217-230 (2007).
51. Guo, F., et al. Canonical Wnt signaling in the oligodendroglial lineage-puzzles remain. Glia 63, 1671-1693 (2015).
52. Ruzov, A., et al. Kaiso is a genome-wide repressor of transcription that is essential for amphibian development. Development 131, 6185-6194 (2004).
53. Arce, L., Pate, K. T. & Waterman, M. L. Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression. BMC Cancer 9, 159 (2009).
54. Lopez-Anido, C., et al. Differential Sox10 genomic occupancy in myelinating glia. Glia 63, 1897-1914 (2015).
55. Norton, L., et al. The mechanisms of genome-wide target gene regulation by TCF7L2 in liver cells. Nucleic Acids Res. 42, 13646-13661 (2014).
56. Fu, H., Kesari, S. & Cai, J. Tcf7l2 is tightly controlled during myelin formation. Cell. Mol. Neurobiol. 32, 345-352 (2012).
57. Lurbke, A., et al. Limited TCF7L2 expression in MS lesions. PLoS ONE 8, e72822 (2013).
58. Ng, M. C., et al. Meta-Analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. PLoS Genet. 10, e1004517 (2014).
59. Shu, L., et al. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum. Mol. Genet. 18, 2388-2399 (2009).
60. Saxena, R., et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55, 2890-2895 (2006).
61. Yatomi, Y., et al. Reduced proliferation and survival of oligodendrocyte progenitor cells in ischemic white matter lesions due to type 2 diabetes. Neuroscience 289, 214-223 (2015).
62. Ligon, K. L., et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53, 503-517 (2007).
63. Lu, Q. R., et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109, 75-86 (2002).
64. Chen, Y., et al. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat. Protoc. 2, 1044-1051 (2007).
65. Chan, J. R., et al. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43, 183-191 (2004).
66. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).